Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
35.03
-0.97 (-2.69%)
Oct 21, 2025, 4:00 PM EDT - Market closed
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $1.35 billion as of October 21, 2025. Its market cap has increased by 64.77% in one year.
Market Cap
1.35B
Enterprise Value
1.05B
1-Year Change
64.77%
Ranking
Category
Stock Price
$35.03
Market Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $1.35B, an increase of 731.21%. That is a compound annual growth rate of 172.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 1.35B | 109.98% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.80B |
| Johnson & Johnson | 462.11B |
| AbbVie | 408.76B |
| UnitedHealth Group | 330.91B |
| AstraZeneca | 259.08B |
| Novartis AG | 254.71B |
| Novo Nordisk | 245.28B |
| Abbott Laboratories | 221.98B |